Oklahoma Attorney General Mike Hunter reached an $8.75 million settlement with Endo Pharmaceuticals, adding to the hundreds of millions of dollars the state already has obtained for costs associated with the opioid crisis.

In a Friday announcement, Hunter said he reached the Endo deal without filing a lawsuit. The state would add the dollars to a fund set up from a previous $85 million settlement reached with Teva Pharmaceuticals last year.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]